13 June 2018 - Deborah Wilkes
Bausch + Lomb is extending its Ocuvite brand in the US with a dietary supplement that is said to "help consumers maintain their eye health in our screen-centric world".
A spokesperson for the eye health specialist told OTCToolbox that the US was the first market for Ocuvite Blue Light. "We are in the process of exploring other market opportunities for Ocuvite Blue Light," she added.
Commenting on the rationale for the launch, Joseph Gordon, president of Consumer Healthcare and Vision Care at Bausch + Lomb, said: "With the increasing number of hours Americans are spending on digital devices, there is a growing need for a product that helps our eyes filter the blue light that is emitted from these devices."
Contains lutein and zeaxanthin
Ocuvite Blue Light contains 25mg lutein and 5mg zeaxanthin, two carotenoid pigments naturally present in the eye. Bausch + Lomb described them as the "key nutrients that help absorb blue light before it reaches the macula".
A strapline on the front of the packaging claims the product "Helps eyes shield and filter blue light".
The company said Ocuvite Blue Light would be available from major retailers in the third quarter of 2018 with a suggested retail price of USD16.99 for a pack of 30 softgels.
Bausch + Lomb is part of Valeant Pharmaceuticals International. The Canadian company recently announced plans to change its name to Bausch Health Companies in July 2018 (click here to read the News story).
Upgrade to an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* Premium News Stories
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE